Test Target Treat™
The misuse of antibiotics has created a huge global health crisis. The Test Target Treat™ initiative from Alere empowers healthcare professionals to make targeted treatment decisions sooner using rapid diagnostics - reducing inappropriate antimicrobial use and the spread of resistance.
Alere provides a suite of tools to support rapid diagnostics and combat antimicrobial resistance in a variety of healthcare settings. Our easy-to-use tests aid in early detection of Strep A, Influenza, RSV, S. pneumoniae, Legionella, MRSA, C. difficile and VTEC Shiga Toxin as well as a point-of-care C-reactive Protein test to indicate bacterial or viral infection. With these tools, early detection enables active stewardship by optimizing patient outcomes and minimizing unintended consequences of antimicrobial use.
Afinion™ CRP test
Results in 4 minutes direct from fingerstick.
Alere BinaxNOW® Influenza A & B
Aids the rapid diagnosis of Influenza A & B in 15 minutes.
Alere BinaxNOW® RSV
Aids in the diagnosis of RSV in patients under the age of 5.
Alere BinaxNOW® S. pneumoniae
A urine antigen test for the qualitative detection of Streptococcus pneumoniae.
Alere BinaxNOW® Legionella
Provides accurate, rapid identification of Legionnaires’ disease caused by Legionella pneumophila serogroup 1
Alere™ PBP2a Culture Colony Test
Aids in the identification of MRSA from plate colonies in 6 minutes.
C. DIFF QUIK CHEK COMPLETE®
Uniquely detects the Glutamate Dehydrogenase antigen (GDH) and Toxins A and B in less than 30 minutes.